Regolo's research reveals 75% of EU businesses inadvertently expose customer data to foreign surveillance.

For small to mid-sized pharma, CROs, or biotechs in Europe, this isn't just a compliance issue; it’s a foundational risk. Using US-based cloud AI tools without proper data residency safeguards means your sensitive data could be legally accessed by foreign governments. Your "transformation" might just be a compliance nightmare waiting for the EU AI Act to bite. I've seen this movie before, with different tech, same plot.